GABRA4
Gamma-aminobutyric acid receptor subunit alpha-4
Also known as: GBRA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48169
- Gene
- GABRA4
- Ensembl
- ENSG00000109158
- Chromosome
- 4
- Canonical length
- 554 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins
OverviewNCBI Gene
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. This gene encodes subunit alpha-4, which is involved in the etiology of autism and eventually increases autism risk through interaction with another subunit, gamma-aminobutyric acid receptor beta-1 (GABRB1). Alternatively spliced transcript variants encoding different isoforms have been found in this gene.[provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
554 residues, UniProt reviewed canonical sequence.
>P48169|GABRA4
1 MVSAKKVPAI ALSAGVSFAL LRFLCLAVCL NESPGQNQKE EKLCTENFTR ILDSLLDGYD
61 NRLRPGFGGP VTEVKTDIYV TSFGPVSDVE MEYTMDVFFR QTWIDKRLKY DGPIEILRLN
121 NMMVTKVWTP DTFFRNGKKS VSHNMTAPNK LFRIMRNGTI LYTMRLTISA ECPMRLVDFP
181 MDGHACPLKF GSYAYPKSEM IYTWTKGPEK SVEVPKESSS LVQYDLIGQT VSSETIKSIT
241 GEYIVMTVYF HLRRKMGYFM IQTYIPCIMT VILSQVSFWI NKESVPARTV FGITTVLTMT
301 TLSISARHSL PKVSYATAMD WFIAVCFAFV FSALIEFAAV NYFTNIQMEK AKRKTSKPPQ
361 EVPAAPVQRE KHPEAPLQNT NANLNMRKRT NALVHSESDV GNRTEVGNHS SKSSTVVQES
421 SKGTPRSYLA SSPNPFSRAN AAETISAARA LPSASPTSIR TGYMPRKASV GSASTRHVFG
481 SRLQRIKTTV NTIGATGKLS ATPPPSAPPP SGSGTSKIDK YARILFPVTF GAFNMVYWVV
541 YLSKDTMEKS ESLMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GABRA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 9.3 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 9.3 nTPM
- basal ganglia: 8.2 nTPM
- amygdala: 2.6 nTPM
- heart muscle: 2.4 nTPM
- hippocampal formation: 1.8 nTPM
- hypothalamus: 1.6 nTPM
Single-cell type
- brain inhibitory neurons: 153 nCPM
- bergmann glia: 131 nCPM
- brain excitatory neurons: 75 nCPM
- other brain neurons: 59 nCPM
- lactotrophs: 57 nCPM
- cardiomyocytes: 52 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 29 nTPM
- basal ganglia: 29 nTPM
- hypothalamus: 17 nTPM
- white matter: 13 nTPM
- amygdala: 13 nTPM
- thalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 2
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system development
- chloride transmembrane transport
- gamma-aminobutyric acid signaling pathway
- inhibitory synapse assembly
- synaptic transmission, GABAergic
Molecular functions
- benzodiazepine receptor activity
- GABA-A receptor activity
- GABA-gated chloride ion channel activity
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Gamma-aminobutyric-acid A receptor, alpha subunit
- Gamma-aminobutyric acid A receptor/Glycine receptor alpha
- Neurotransmitter-gated ion-channel transmembrane domain
- Neurotransmitter-gated ion-channel
- Neurotransmitter-gated ion-channel ligand-binding domain
- Neurotransmitter-gated ion-channel, conserved site
- Neurotransmitter-gated ion-channel transmembrane domain superfamily
- Neurotransmitter-gated ion-channel ligand-binding domain superfamily
- Neuronal acetylcholine receptor
- Gamma-aminobutyric acid receptor subunit alpha 1-6, transmembrane domain
- Neurotransmitter-gated ion-channel ligand binding domain
- Neurotransmitter-gated ion-channel transmembrane region
- Gamma-aminobutyric-acid A receptor, alpha 4 subunit
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GABRA4 as an antibody target. Whether an autoantibody or antibody against GABRA4 could matter depends on whether native GABRA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GABRA4 is annotated at the cell surface, where native GABRA4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GABRA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...